European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-05-27

Mucus Permeating Nanoparticulate Drug Delivery Systems

Cel

The objective of the ALEXANDER project is the identification of novel strategies (e.g. proteolytic enzyme strategy, thiomer strategy, zeta potential changing systems, SNEDDS strategy) and the optimization of existing strategies (e.g. disulfide breaking strategy and slippery surface strategy) for the efficient transport of nanocarriers through the mucus gel layer (e.g. intestinal, nasal, ocular, vaginal, buccal, pulmonary). In particular, R&D activities will be focused on the synthesis of functionalized nanocarriers capable of permeating the mucus gel layer and delivering their therapeutic payload to the epithelium. The nanocarriers will be characterized with respect to their physicochemical properties, ability to cross the mucus gel layer, in vitro and in vivo cytotoxicity. The potential of the developed nanocarriers as delivery systems for mucosal administration of macromolecules will be demonstrated via the oral delivery of peptides, oligosaccharides and oligonucleotides and the nasal delivery of a plasmid encoding for an antigen.

Zaproszenie do składania wniosków

FP7-NMP-2011-LARGE-5
Zobacz inne projekty w ramach tego zaproszenia

Koordynator

DECHEMA GESELLSCHAFT FUR CHEMISCHETECHNIK UND BIOTECHNOLOGIE
Wkład UE
€ 1 015 908,63
Adres
THEODOR HEUSS ALLEE 25
60486 Frankfurt
Niemcy

Zobacz na mapie

Region
Hessen Darmstadt Frankfurt am Main, Kreisfreie Stadt
Rodzaj działalności
Research Organisations
Kontakt administracyjny
Andreas Förster (Dr.)
Linki
Koszt całkowity
Brak danych

Uczestnicy (18)